Skip to main navigation Skip to search Skip to main content

Differences in presentation, severity and management of DKA in type 1 and type 2 diabetes during the COVID-19 pandemic

  • Lucy Wallett
  • , Punith Kempegowda
  • , Eka Melson
  • , Agata Juszczak
  • , Lucretia Thomas
  • , Dengyi Zhou
  • , Catherine Holmes
  • , Muhammad Ali Karamat
  • , Sandip Ghosh
  • , Wasim Hanif
  • , Agnes Johnson
  • , Parth Narendran
  • , Srikanth Bellary

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)s1-s2
Number of pages2
JournalClinical Medicine
Volume21
Issue numberSuppl 2
DOIs
Publication statusPublished - 2 Jun 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • COVID-19
  • Diabetes Mellitus, Type 2/complications
  • Diabetic Ketoacidosis/epidemiology
  • Humans
  • Pandemics
  • SARS-CoV-2

Cite this